Factors Likely to Have Influenced Earnings Results NYSE:KBH, NYSE:RAD, NASDAQ:ENVB, NASDAQ:TYHT

0
40

Earnings Summary (NYSE:KBH)

KB Home last posted its quarterly earnings data on September 21st, 2021. The construction company reported $1.60 earnings per share for the quarter, meeting analysts’ consensus estimates of $1.60. The company earned $1.47 billion during the quarter, compared to analyst estimates of $1.56 billion. Its quarterly revenue was up 46.9% on a year-over-year basis. KB Home has generated $3.13 earnings per share over the last year ($4.47 diluted earnings per share) and currently has a price-to-earnings ratio of 9.2. Earnings for KB Home are expected to grow by 12.52% in the coming year, from $6.23 to $7.01 per share. KB Home has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Tuesday, January 11th, 2022 based off prior year’s report dates.

IS KB HOME A BUY RIGHT NOW? (NYSE:KBH)

14 Wall Street equities research analysts have issued “buy,” “hold,” and “sell” ratings for KB Home in the last year. There are currently 5 hold ratings, 8 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should “buy” KB Home stock.
KB Home

Earnings Summary (NYSE:RAD)

Rite Aid last released its quarterly earnings data on September 22nd, 2021. The reported ($0.41) EPS for the quarter, topping analysts’ consensus estimates of ($0.48) by $0.07. The firm had revenue of $6.11 billion for the quarter, compared to analyst estimates of $6.21 billion. Its revenue for the quarter was up 2.2% compared to the same quarter last year. Rite Aid has generated ($0.15) earnings per share over the last year (($0.75) diluted earnings per share). Earnings for Rite Aid are expected to grow in the coming year, from ($0.80) to ($0.23) per share. Rite Aid has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Thursday, December 16th, 2021 based off prior year’s report dates.

IS RITE AID A BUY RIGHT NOW? (NYSE:RAD)

2 Wall Street analysts have issued “buy,” “hold,” and “sell” ratings for Rite Aid in the last year. There are currently 1 sell rating and 1 hold rating for the stock. The consensus among Wall Street analysts is that investors should “hold” Rite Aid stock. A hold rating indicates that analysts believe investors should maintain any existing positions they have in RAD, but not buy additional shares or sell existing shares.
Rite Aid

ENVERIC BIOSCIENCES (NASDAQ:ENVB) EARNINGS HISTORY BY QUARTER (NASDAQ:ENVB)

Enveric Biosciences has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, November 15th, 2021 based off prior year’s report dates.

IS ENVERIC BIOSCIENCES A BUY RIGHT NOW? (NASDAQ:ENVB)

2 Wall Street research analysts have issued “buy,” “hold,” and “sell” ratings for Enveric Biosciences in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should “buy” Enveric Biosciences stock.
Enveric Biosciences

SHINECO (NASDAQ:TYHT) EARNINGS HISTORY BY QUARTER (NASDAQ:TYHT)

Shineco has not formally confirmed its next earnings publication date, but the company’s estimated earnings date is Monday, September 27th, 2021 based off prior year’s report dates.

WHAT STOCKS DOES MARKETBEAT LIKE BETTER THAN SHINECO? (NASDAQ:TYHT)

Wall Street analysts have given Shineco a “N/A” rating, but there may be better buying opportunities in the stock market. Some of MarketBeat’s past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Shineco wasn’t one of them. MarketBeat thinks these five companies may be even better buys.